Aripiprazole: dose-response relationship in schizophrenia and schizoaffective disorder.
about
Aripiprazole dose for schizophreniaA case of aripiprazole induced tardive dyskinesia in a neuroleptic-naïve patient with two years of follow up.Dose Trends of Aripiprazole from 2004 to 2014 in Psychiatric Inpatients in KoreaReducing the rates of prescribing high-dose antipsychotics and polypharmacy on psychiatric inpatient and intensive care units: results of a 6-year quality improvement programme.Aripiprazole and Haloperidol Activate GSK3β-Dependent Signalling Pathway Differentially in Various Brain Regions of Rats.A potential mechanism underlying atypical antipsychotics-induced lipid disturbancesPsychotic exacerbation and emotional dampening in the daily life of patients with schizophrenia switched to aripiprazole therapy: a collection of standardized case reports.Chronic administration of aripiprazole activates GSK3β-dependent signalling pathways, and up-regulates GABAA receptor expression and CREB1 activity in ratsEffect of aripiprazole on cognitive function and hyperprolactinemia in patients with schizophrenia treated with risperidoneApplications of imaging biomarkers in the early clinical development of central nervous system therapeutic agents.Intramuscular aripiprazole in the acute management of psychomotor agitation.Aripiprazole Increases the PKA Signalling and Expression of the GABAA Receptor and CREB1 in the Nucleus Accumbens of Rats.Add-on Aripiprazole for Atypical Antipsychotic-induced, Clinically Significant Hyperprolactinemia.
P2860
Q24200753-DF1003EB-00BB-4500-9B2F-55BBC9E60ABAQ33618959-D47D0587-CC3B-4F7C-A61F-B5BE17BE91F3Q33662847-330935B0-79A0-46BE-A7A6-B97580BB97EBQ35044176-9B171F8E-DDB4-4B68-A87F-E12B327A32BFQ36846918-F323EF51-39B8-4BE8-A83C-F83345187E47Q37058653-9169146E-B6A6-46B5-A6A7-C2119DAB4EE6Q37078959-9C9EF473-BA8C-44B2-B487-C3E937E74DBBQ37111054-E0D40CF1-C2E6-4571-BC0E-9EE198A041CAQ37155297-D90CF638-2F7C-4DC0-927C-46139F145F67Q37973222-774BC470-54E9-417E-B1CD-2B39C3C4DAC8Q46703897-2FAD226D-EB2F-4859-8E1D-56BD436DD874Q48234174-50A82176-5ABE-4B66-A696-BF9F42482922Q48512330-3128E6D0-4BE1-455E-83B2-C873063C6A9F
P2860
Aripiprazole: dose-response relationship in schizophrenia and schizoaffective disorder.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Aripiprazole: dose-response relationship in schizophrenia and schizoaffective disorder.
@en
Aripiprazole: dose-response relationship in schizophrenia and schizoaffective disorder.
@nl
type
label
Aripiprazole: dose-response relationship in schizophrenia and schizoaffective disorder.
@en
Aripiprazole: dose-response relationship in schizophrenia and schizoaffective disorder.
@nl
prefLabel
Aripiprazole: dose-response relationship in schizophrenia and schizoaffective disorder.
@en
Aripiprazole: dose-response relationship in schizophrenia and schizoaffective disorder.
@nl
P1433
P1476
Aripiprazole: dose-response relationship in schizophrenia and schizoaffective disorder.
@en
P2093
Shubhra Mace
P2860
P304
P356
10.2165/11310820-000000000-00000
P50
P577
2009-09-01T00:00:00Z
P6179
1036965795